Patent 7727742 was granted and assigned to Amgen on June, 2010 by the United States Patent and Trademark Office.
The present invention provides nucleic acid molecules encoding Fibroblast Growth Factor-like (FGF-like) polypeptides. The invention also provides vectors, host cells, and methods for producing FGF-like polypeptides.